GLP-1 Support
US$ 23.32
semaglutide potency Incretins: How we got here, where we're at and what is coming next While only three medications have
Description
Fast & Effective Weight Loss
In a phase 2 study, amycretin showed a mean weight reduction of up to 24.3%, which is comparable to or even greater than the weight loss seen with tirzepatide and similar to the results for retatrutide
Crucially, weight regain after discontinuation is common
This multi-agonist compoundtargeting GLP-1, GIP, and glucagon receptorsis being investigated for its potential influence on metabolic pathways, energy regulation, and appetite control
